Rucaparib Recruiting Phase 1 Trials for Folate Receptor Alpha Positive / Recurrent Ovarian Carcinoma / Recurrent Uterine Carcinosarcoma / Platinum Resistant Ovarian Cancer / brca2 Gene Mutation / Recurrent Primary Peritoneal Carcinoma / Recurrent Uterine Corpus Carcinoma / BRCA1 Gene Mutation / Recurrent Fallopian Tube Carcinoma / Recurrent Uterine Serous Carcinoma Treatment